Brian Lockhart
Global Head of Companion Diagnostics Servier
Seminars
Thursday 25th September 2025
Panel Discussion: Paving Towards Strategic Drug-Diagnostic Market Entry in China – From Trial Design to Commercial Success
9:00 am
- Which potential challenges in trial design are we aware of?
- Which CDx strategy and testing models are optimal for maximizing market patient access in China?
- What are the CDx policies and regulations across China, and how can we address critical bottlenecks regarding regulatory adherence and commercialization?
- What precision medicine marker developments are currently underway which might change the future testing paradigm? How might this inform vendor selection?
Tuesday 23rd September 2025
Around the CDx World in 80 Days: Navigating Companion Diagnostics Challenges from US to Japan to China to EU
11:50 am
- Presenting recent case-studies on CDx filings/approvals in US, Japan, China and EU territories from the Pharma perspective
- Highlighting issues to anticipate and challenges to expect and learn to expect the unexpected
- Working with accelerated approvals timelines
- The importance of ‘Local’ knowledge
- Terra incognita … IVD filings beyond the Big 4
